首页 > 最新文献

Future Science OA最新文献

英文 中文
In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer's disease like pathology. 从油辣木根中提取的葡萄糖络氨酸对类似阿尔茨海默氏症的病理学进行硅学和药代动力学研究。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0255
Chintalapati Manogna, Thirumal Margesan

Aim: The aim of this research is to investigate the potential of glucomoringin, derived from Moringa oleifera, as a therapeutic agent for Alzheimer's disease through in silico analysis. Materials & methods: This study employs in silico or computational methodologies, including pkCSM, Swiss ADME, OSIRIS® property explorer, PASS online web resource and MOLINSPIRATION® software, to predict the pharmacokinetic characteristics and biological activity of glucomoringin. Results & conclusion: Molecular docking indicates strong binding to I-1β and the pharmacokinetic profile shows cytochrome P450 enzyme inhibition, prompting further research for dosing strategies. Toxicological predictions affirm safety, while bioactivity assessments demonstrate versatility in modulating essential pathways. glucomoringin's potential for Alzheimer's treatment, emphasizing the need for additional empirical research.

目的:本研究的目的是通过硅学分析,研究从油橄榄辣木中提取的葡萄糖络氨酸作为阿尔茨海默病治疗剂的潜力。材料与方法:本研究采用硅学或计算方法,包括 pkCSM、Swiss ADME、OSIRIS® Property explorer、PASS 在线网络资源和 MOLINSPIRATION® 软件,预测葡萄糖络氨酸的药代动力学特征和生物活性。结果与结论分子对接表明葡萄糖络合素与 I-1β 有很强的结合力,药代动力学特征表明葡萄糖络合素对细胞色素 P450 酶有抑制作用,这促使我们进一步研究用药策略。毒理学预测肯定了其安全性,而生物活性评估则显示了其在调节重要通路方面的多功能性。
{"title":"<i>In silico</i> and pharmacokinetic studies of glucomoringin from <i>Moringa oleifera</i> root for Alzheimer's disease like pathology.","authors":"Chintalapati Manogna, Thirumal Margesan","doi":"10.2144/fsoa-2023-0255","DOIUrl":"10.2144/fsoa-2023-0255","url":null,"abstract":"<p><p><b>Aim:</b> The aim of this research is to investigate the potential of glucomoringin, derived from <i>Moringa oleifera</i>, as a therapeutic agent for Alzheimer's disease through <i>in silico</i> analysis. <b>Materials & methods:</b> This study employs <i>in silico</i> or computational methodologies, including pkCSM, Swiss ADME, OSIRIS<sup>®</sup> property explorer, PASS online web resource and MOLINSPIRATION<sup>®</sup> software, to predict the pharmacokinetic characteristics and biological activity of glucomoringin. <b>Results & conclusion:</b> Molecular docking indicates strong binding to <i>I-1β</i> and the pharmacokinetic profile shows cytochrome P450 enzyme inhibition, prompting further research for dosing strategies. Toxicological predictions affirm safety, while bioactivity assessments demonstrate versatility in modulating essential pathways. glucomoringin's potential for Alzheimer's treatment, emphasizing the need for additional empirical research.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"2340280"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance pattern and uropathogens distribution in children visiting a referral hospital in Mogadishu. 摩加迪沙一家转诊医院就诊儿童的抗菌药耐药性模式和尿路病原体分布。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0298
Abdikarin Ahmed Mohamed, Yavuz Bastug, Cem Senol, Mohamed Muktar Kassim, Abdisalam Abdullahi Yusuf, Abdikarim Hussein Mohamed

Aim: Studies concerning epidemiology and drug susceptibility patterns of pediatric urinary tract infection in developing countries are scarce. This study aimed to evaluate the antimicrobial resistance pattern and uropathogens distribution in children. Method: Four-year retrospective study included 840 participants in all pediatric age groups whose urine had been cultured. Results: The prevalence of culture-proven pediatric UTIs was 17.6% (148/840). Escherichia coli was the most common pathogen isolated from the cultures, accounting for (48%, 71/148), followed by Klebsiella pneumoniae (16.2%, 24/148). About 27% of the pathogens had a multidrug-resistant (MDR) pattern. A resistance rate against nitrofurantoin at 24.6%, fosfomycin at 15.2% and trimethoprim-sulfamethoxazole (SMX-TMP) at 79.7% was noted. Conclusion: E. coli and Klebsiella pneumoniae were the most common pathogens isolated.

目的:有关发展中国家儿童尿路感染的流行病学和药物敏感性模式的研究很少。本研究旨在评估儿童的抗菌药耐药性模式和尿路病原体分布。研究方法为期四年的回顾性研究纳入了 840 名尿液经过培养的所有儿童年龄组的参与者。研究结果经培养证实的儿科尿路感染发病率为 17.6%(148/840)。大肠埃希菌是从培养物中分离出的最常见病原体,占 48%(71/148),其次是肺炎克雷伯菌(16.2%,24/148)。约 27% 的病原体具有耐多药(MDR)模式。对硝基呋喃妥因的耐药率为 24.6%,对磷霉素的耐药率为 15.2%,对三甲双胍-磺胺甲恶唑(SMX-TMP)的耐药率为 79.7%。结论大肠杆菌和肺炎克雷伯菌是最常见的病原体。
{"title":"Antimicrobial resistance pattern and uropathogens distribution in children visiting a referral hospital in Mogadishu.","authors":"Abdikarin Ahmed Mohamed, Yavuz Bastug, Cem Senol, Mohamed Muktar Kassim, Abdisalam Abdullahi Yusuf, Abdikarim Hussein Mohamed","doi":"10.2144/fsoa-2023-0298","DOIUrl":"10.2144/fsoa-2023-0298","url":null,"abstract":"<p><p><b>Aim:</b> Studies concerning epidemiology and drug susceptibility patterns of pediatric urinary tract infection in developing countries are scarce. This study aimed to evaluate the antimicrobial resistance pattern and uropathogens distribution in children. <b>Method:</b> Four-year retrospective study included 840 participants in all pediatric age groups whose urine had been cultured. <b>Results:</b> The prevalence of culture-proven pediatric UTIs was 17.6% (148/840). <i>Escherichia coli</i> was the most common pathogen isolated from the cultures, accounting for (48%, 71/148), followed by <i>Klebsiella pneumoniae</i> (16.2%, 24/148). About 27% of the pathogens had a multidrug-resistant (MDR) pattern. A resistance rate against nitrofurantoin at 24.6%, fosfomycin at 15.2% and trimethoprim-sulfamethoxazole (SMX-TMP) at 79.7% was noted. <b>Conclusion:</b> <i>E. coli</i> and <i>Klebsiella pneumoniae</i> were the most common pathogens isolated.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO978"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trans-femoral versus trans-carotid access for transcatheter aortic valve replacement: an updated systematic review and meta-analysis. 经股动脉与经颈动脉入路进行经导管主动脉瓣置换术:最新系统综述和荟萃分析。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0101
Naser Yamani, Syed Hasham Ali, Mahnoor Sadiq, Afeera B Ahmed, Kapil D Bhojwani, Vivek P Lohana, Saba Fatmah, Shazra Khalid, Hammad R Shamsi, Batool Zehra, Kaneez Fatima, Zulfiqar Q Baloch

Aim: This meta-analysis aims to shed light on any primacy the trans-carotid (TC-TAVR) access may have over the trans-femoral access (TF-TAVR) for those undergoing transcatheter aortic valve replacement (TAVR). Methods: PubMed/MEDLINE and Cochrane Library were searched, from inception to March 2023 retrieving seven adjusted studies with a total of 6609 patients, of which 5048 underwent TF-TAVR while 1561 underwent TC-TAVR. Results: No divergence in risk of mortality, major bleeding or stroke/transient ischemic attack in TC-TAVR when compared with TF-TAVR was found. In TC-TAVR, the risk of vascular complications was low (OR: 0.51, 95% CI: 0.32-0.83, p = 0.003) as compared with TF-TAVR. Conclusion: As of this analysis, the viability of TC-TAVR as first alternative to TF-TAVR is plausible.

目的:本荟萃分析旨在阐明在接受经导管主动脉瓣置换术(TAVR)的患者中,经颈动脉入路(TC-TAVR)可能比经股动脉入路(TF-TAVR)更重要。方法:对 PubMed/MEDLINE 和 Cochrane 图书馆进行了检索,检索时间从开始到 2023 年 3 月,共检索到 7 项经过调整的研究,涉及 6609 名患者,其中 5048 人接受了 TF-TAVR,1561 人接受了 TC-TAVR。研究结果与TF-TAVR相比,TC-TAVR的死亡率、大出血或中风/短暂性脑缺血发作风险没有差异。与 TF-TAVR 相比,TC-TAVR 的血管并发症风险较低(OR:0.51,95% CI:0.32-0.83,P = 0.003)。结论从这项分析来看,TC-TAVR 作为 TF-TAVR 的第一替代方案是可行的。
{"title":"Trans-femoral versus trans-carotid access for transcatheter aortic valve replacement: an updated systematic review and meta-analysis.","authors":"Naser Yamani, Syed Hasham Ali, Mahnoor Sadiq, Afeera B Ahmed, Kapil D Bhojwani, Vivek P Lohana, Saba Fatmah, Shazra Khalid, Hammad R Shamsi, Batool Zehra, Kaneez Fatima, Zulfiqar Q Baloch","doi":"10.2144/fsoa-2023-0101","DOIUrl":"10.2144/fsoa-2023-0101","url":null,"abstract":"<p><p><b>Aim:</b> This meta-analysis aims to shed light on any primacy the <i>trans</i>-carotid (TC-TAVR) access may have over the <i>trans</i>-femoral access (TF-TAVR) for those undergoing transcatheter aortic valve replacement (TAVR). <b>Methods:</b> PubMed/MEDLINE and Cochrane Library were searched, from inception to March 2023 retrieving seven adjusted studies with a total of 6609 patients, of which 5048 underwent TF-TAVR while 1561 underwent TC-TAVR. <b>Results:</b> No divergence in risk of mortality, major bleeding or stroke/transient ischemic attack in TC-TAVR when compared with TF-TAVR was found. In TC-TAVR, the risk of vascular complications was low (OR: 0.51, 95% CI: 0.32-0.83, p = 0.003) as compared with TF-TAVR. <b>Conclusion:</b> As of this analysis, the viability of TC-TAVR as first alternative to TF-TAVR is plausible.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO930"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-partum hemorrhage: a multidisciplinary approach to 'the golden hour' quantum leadership and communication. 产后出血:"黄金时间 "量子领导与沟通的多学科方法。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0076
Georges Yared, Jihad Al Hasssan, Charlotte Al Hajjar, Kariman Ghazal

Background: Quantum leadership in postpartum hemorrhage (PPH) simulation training remains underexplored. Quantum leaders excel in PPH's chaotic settings, differing from traditional leaders. Aiming: To assess the impact of simulation training on quantum leadership skills in maternity teams. Research design: A quasi-experimental approach. Sample: 60 maternity professionals from Rafik Hariri University Hospital, Lebanon. Tools: Structured interviews, observational checklists and a leadership skills scale. Results: Most participants had limited PPH simulation experience and showed an initial low proficiency. Significant improvements were evident, post training. Conclusion: Simulation training enhances quantum leadership in PPH management among maternity professionals.

背景:产后出血(PPH)模拟训练中的量子领导力仍未得到充分探索。量子领导在 PPH 的混乱环境中表现出色,有别于传统领导。目的评估模拟训练对产科团队量子领导技能的影响。研究设计:准实验方法。样本:来自黎巴嫩拉菲克-哈里里大学医院的 60 名产科专业人员。工具:结构化访谈、观察清单和领导技能量表。结果大多数参与者的 PPH 模拟经验有限,最初的熟练程度较低。培训后,学员的水平明显提高。结论模拟培训提高了产科专业人员在 PPH 管理中的量子领导力。
{"title":"Post-partum hemorrhage: a multidisciplinary approach to 'the golden hour' quantum leadership and communication.","authors":"Georges Yared, Jihad Al Hasssan, Charlotte Al Hajjar, Kariman Ghazal","doi":"10.2144/fsoa-2023-0076","DOIUrl":"10.2144/fsoa-2023-0076","url":null,"abstract":"<p><p><b>Background:</b> Quantum leadership in postpartum hemorrhage (PPH) simulation training remains underexplored. Quantum leaders excel in PPH's chaotic settings, differing from traditional leaders. <b>Aiming:</b> To assess the impact of simulation training on quantum leadership skills in maternity teams. <b>Research design:</b> A quasi-experimental approach. <b>Sample:</b> 60 maternity professionals from Rafik Hariri University Hospital, Lebanon. <b>Tools:</b> Structured interviews, observational checklists and a leadership skills scale. <b>Results:</b> Most participants had limited PPH simulation experience and showed an initial low proficiency. Significant improvements were evident, post training. <b>Conclusion:</b> Simulation training enhances quantum leadership in PPH management among maternity professionals.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO905"},"PeriodicalIF":2.5,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic exploration of network pharmacology, in silico modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome. 系统探索多囊卵巢综合征中维生素 E 的网络药理学、硅学建模和药代动力学分析。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-15 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0245
Rukaiah Fatma Begum, Sumithra Mohan

Aim: This study seeks to explore the possibility of using vitamin E to alleviate the symptoms of polycystic ovarian syndrome (PCOS). Methods: Various computational methods were employed, including network pharmacology utilizing a compound-target-pathway approach, Swiss ADME, OSIRIS® property explorer, pkCSM, PASS online web resource and MOLINSPIRATION® software. In addition, in silico analysis of vitamin E was performed with ten receptors. Results & discussion: Our findings highlight the diverse potential of vitamin E in alleviating PCOS. The observed influence on hormones is in line with existing PCOS theories regarding cyst development, further enhancing the therapeutic promise of vitamin E. Conclusion: In conclusion, our computational analysis indicates that vitamin E shows potential as a therapeutic agent for alleviating PCOS in adolescents.

目的:本研究旨在探讨使用维生素 E 缓解多囊卵巢综合征(PCOS)症状的可能性。研究方法:采用了多种计算方法,包括利用化合物-目标-途径方法的网络药理学、Swiss ADME、OSIRIS® Property explorer、pkCSM、PASS 在线网络资源和 MOLINSPIRATION® 软件。此外,还利用十种受体对维生素 E 进行了硅学分析。结果与讨论我们的研究结果凸显了维生素 E 在缓解多囊卵巢综合症方面的多种潜力。观察到的对激素的影响与现有的多囊卵巢综合症关于囊肿发展的理论相一致,进一步增强了维生素 E 的治疗前景:总之,我们的计算分析表明,维生素 E 具有缓解青少年多囊卵巢综合症的治疗潜力。
{"title":"Systematic exploration of network pharmacology, <i>in silico</i> modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome.","authors":"Rukaiah Fatma Begum, Sumithra Mohan","doi":"10.2144/fsoa-2023-0245","DOIUrl":"10.2144/fsoa-2023-0245","url":null,"abstract":"<p><p><b>Aim:</b> This study seeks to explore the possibility of using vitamin E to alleviate the symptoms of polycystic ovarian syndrome (PCOS). <b>Methods:</b> Various computational methods were employed, including network pharmacology utilizing a compound-target-pathway approach, Swiss ADME, OSIRIS<sup>®</sup> property explorer, pkCSM, PASS online web resource and MOLINSPIRATION<sup>®</sup> software. In addition, <i>in silico</i> analysis of vitamin E was performed with ten receptors. <b>Results & discussion:</b> Our findings highlight the diverse potential of vitamin E in alleviating PCOS. The observed influence on hormones is in line with existing PCOS theories regarding cyst development, further enhancing the therapeutic promise of vitamin E. <b>Conclusion:</b> In conclusion, our computational analysis indicates that vitamin E shows potential as a therapeutic agent for alleviating PCOS in adolescents.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO952"},"PeriodicalIF":2.4,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis. 肝硬化患者耐多药细菌感染的临床影响。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0160
Nouha Trad, Ghanem Mohamed, Sondes Bizid, Hatem Ben Abdallah, Riadh Bouali, Mohamed Nabil Abdelli

Aim: Recently, the emergency of multidrug-resistant organisms (MDRO) has complicated the management of bacterial infections (BI) in cirrhosis. We aimed to assess their clinical impact on patients with decompensated cirrhosis. Methods: A retrospective study included consecutive cirrhotic patients hospitalized for acute decompensation (AD) between January 2010 and December 2019. Results: A total of 518 AD admissions in 219 patients were included, with 260 BI episodes (50.2%). MDRO prevalence was 38.2% of the total isolates. Recent antibiotic use (OR = 4.91), nosocomial infection (OR = 2.95), and healthcare-associated infection (OR = 3.45) were their main risk factors. MDROs were associated with empiric treatment failure (OR = 23.42), a higher prevalence of sepsis (OR = 4.93), ACLF (OR = 3.42) and mortality. Conclusion: The clinical impact of MDROs was pejorative, with an increased risk of empiric treatment failure, organ failure and death.

目的:最近,耐多药生物(MDRO)的紧急出现使肝硬化患者细菌感染(BI)的治疗变得更加复杂。我们旨在评估它们对肝硬化失代偿期患者的临床影响。研究方法回顾性研究纳入了 2010 年 1 月至 2019 年 12 月期间因急性失代偿(AD)住院的连续肝硬化患者。研究结果共纳入 219 名患者的 518 例急性失代偿住院病例,其中 260 例 BI(50.2%)。MDRO感染率占分离菌总数的38.2%。近期使用抗生素(OR = 4.91)、院内感染(OR = 2.95)和医疗相关感染(OR = 3.45)是其主要风险因素。MDROs与经验性治疗失败(OR = 23.42)、较高的败血症发病率(OR = 4.93)、ACLF(OR = 3.42)和死亡率有关。结论MDROs的临床影响是严重的,会增加经验性治疗失败、器官衰竭和死亡的风险。
{"title":"Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.","authors":"Nouha Trad, Ghanem Mohamed, Sondes Bizid, Hatem Ben Abdallah, Riadh Bouali, Mohamed Nabil Abdelli","doi":"10.2144/fsoa-2023-0160","DOIUrl":"10.2144/fsoa-2023-0160","url":null,"abstract":"<p><p><b>Aim:</b> Recently, the emergency of multidrug-resistant organisms (MDRO) has complicated the management of bacterial infections (BI) in cirrhosis. We aimed to assess their clinical impact on patients with decompensated cirrhosis. <b>Methods:</b> A retrospective study included consecutive cirrhotic patients hospitalized for acute decompensation (AD) between January 2010 and December 2019. <b>Results:</b> A total of 518 AD admissions in 219 patients were included, with 260 BI episodes (50.2%). MDRO prevalence was 38.2% of the total isolates. Recent antibiotic use (OR = 4.91), nosocomial infection (OR = 2.95), and healthcare-associated infection (OR = 3.45) were their main risk factors. MDROs were associated with empiric treatment failure (OR = 23.42), a higher prevalence of sepsis (OR = 4.93), ACLF (OR = 3.42) and mortality. <b>Conclusion:</b> The clinical impact of MDROs was pejorative, with an increased risk of empiric treatment failure, organ failure and death.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO945"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11131343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic scores in primary biliary cholangitis. 原发性胆汁性胆管炎的预后评分。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0203
Ramzi Tababi, Soumaya Mrabet, Imen Akkari, Raida Harbi, Elhem Ben Jazia

Aim: Evaluating prognostic scores' utility in predicting ursodeoxycholic acid (UDCA) biochemical response (BR) and long-term liver-related complications in primary biliary cholangitis (PBC) patients. Patients & methods: This retrospective single-center study included 50 predominantly female PBC patients (median age: 56) on UDCA treatment. BR was defined by Paris II criteria. Liver-related complications during a median 76-month follow-up were assessed. APRI, ALBI, Mayo, GLOBE and UK-PBC scores were calculated. Results: 64% achieved BR, while 40% experienced liver-related complications. All scores showed good BR prediction (concordance statistics: 0.76-0.94) and excellent negative predictive values for 5-year liver complications (concordance statistics: 0.73-0.89). Conclusion: Implementing these scores in clinical practice is encouraged due to their effectiveness in predicting BR- and liver-related events.

目的:评估预后评分在预测原发性胆汁性胆管炎(PBC)患者熊去氧胆酸(UDCA)生化反应(BR)和长期肝脏相关并发症方面的实用性。患者和方法:这项回顾性单中心研究纳入了 50 名主要接受 UDCA 治疗的女性 PBC 患者(中位年龄:56 岁)。BR是根据巴黎II标准定义的。对中位随访 76 个月的肝脏相关并发症进行了评估。计算了 APRI、ALBI、Mayo、GLOBE 和 UK-PBC 评分。结果显示64%的患者达到了BR标准,40%的患者出现了肝脏相关并发症。所有评分均显示出良好的 BR 预测性(一致性统计:0.76-0.94)和出色的 5 年肝脏并发症阴性预测值(一致性统计:0.73-0.89)。结论:由于这些评分能有效预测 BR 和肝脏相关事件,因此鼓励在临床实践中采用这些评分。
{"title":"Prognostic scores in primary biliary cholangitis.","authors":"Ramzi Tababi, Soumaya Mrabet, Imen Akkari, Raida Harbi, Elhem Ben Jazia","doi":"10.2144/fsoa-2023-0203","DOIUrl":"10.2144/fsoa-2023-0203","url":null,"abstract":"<p><p><b>Aim:</b> Evaluating prognostic scores' utility in predicting ursodeoxycholic acid (UDCA) biochemical response (BR) and long-term liver-related complications in primary biliary cholangitis (PBC) patients. <b>Patients & methods:</b> This retrospective single-center study included 50 predominantly female PBC patients (median age: 56) on UDCA treatment. BR was defined by Paris II criteria. Liver-related complications during a median 76-month follow-up were assessed. APRI, ALBI, Mayo, GLOBE and UK-PBC scores were calculated. <b>Results:</b> 64% achieved BR, while 40% experienced liver-related complications. All scores showed good BR prediction (concordance statistics: 0.76-0.94) and excellent negative predictive values for 5-year liver complications (concordance statistics: 0.73-0.89). <b>Conclusion:</b> Implementing these scores in clinical practice is encouraged due to their effectiveness in predicting BR- and liver-related events.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO975"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141179432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid storm-induced acute liver dysfunction and portal hypertension in a patient with Graves' disease: a case report. 甲状腺风暴诱发巴塞杜氏病患者急性肝功能异常和门静脉高压:病例报告。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0180
Mouna Medhioub, Amal Khsiba, Moufida Mahmoudi, Asma Ben Mohamed, Manel Yakoubi, Emna Haouet, Lamine Hamzaoui

Thyroid storm is a life-threatening condition associated with multiorgan dysfunction and decompensation. We report the case of a 41-year-old woman having Graves' disease presented with thyroid storm complicated with liver dysfunction and portal hypertension in the absence of congestive heart failure or known liver disease. After successful therapeutic management, all biological, clinical and morphological abnormalities regressed.

甲状腺风暴是一种与多器官功能障碍和失代偿相关的危及生命的疾病。我们报告了一例41岁女性巴塞杜氏病患者的病例,她在没有充血性心力衰竭或已知肝脏疾病的情况下,出现甲状腺风暴并发肝功能异常和门静脉高压。经过成功的治疗后,所有的生物学、临床和形态学异常都得到了缓解。
{"title":"Thyroid storm-induced acute liver dysfunction and portal hypertension in a patient with Graves' disease: a case report.","authors":"Mouna Medhioub, Amal Khsiba, Moufida Mahmoudi, Asma Ben Mohamed, Manel Yakoubi, Emna Haouet, Lamine Hamzaoui","doi":"10.2144/fsoa-2023-0180","DOIUrl":"10.2144/fsoa-2023-0180","url":null,"abstract":"<p><p>Thyroid storm is a life-threatening condition associated with multiorgan dysfunction and decompensation. We report the case of a 41-year-old woman having Graves' disease presented with thyroid storm complicated with liver dysfunction and portal hypertension in the absence of congestive heart failure or known liver disease. After successful therapeutic management, all biological, clinical and morphological abnormalities regressed.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO929"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low dose insulin infusion versus the standard dose in children with diabetic ketoacidosis: a meta-analysis. 糖尿病酮症酸中毒患儿低剂量胰岛素输注与标准剂量胰岛素输注的比较:一项荟萃分析。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0137
Mohamed Mohamed Belal, Basma Badrawy Khalefa, Eslam Mohammed Rabea, Mazen Negmeldin Aly Yassin, Mohamed Nabih Bashir, Malak Mohamed Abd El-Hameed, Omar Elkoumi, Saad Mohamed Saad, Loubna Mohamed Saad, Mohamed Hamouda Elkasaby

Aim: This systematic review aims to consolidate findings from current clinical trials that compare the effectiveness of insulin infusion at 0.05 IU/kg/h versus 0.1 IU/kg/h in managing pediatric diabetic ketoacidosis. Methods: We searched several databases, including PubMed, Embase, Scopus, Cochrane Central and Web of Science. Our primary outcomes were time to reach blood glucose ≤250 mg/dl and time to resolution of acidosis. Secondary outcomes included rate of blood glucose decrease per hour, incidence of hypoglycemia, hypokalemia, treatment failure, and cerebral edema. Results & conclusion: The present study establishes that a low insulin dose exhibits comparable efficacy to the standard dosage for managing pediatric patients suffering from diabetic ketoacidosis, with a lower incidence of complications.

目的:本系统性综述旨在整合当前临床试验的研究结果,这些临床试验比较了胰岛素输注量为 0.05 IU/kg/h 与 0.1 IU/kg/h 对控制小儿糖尿病酮症酸中毒的有效性。方法:我们检索了多个数据库,包括 PubMed、Embase、Scopus、Cochrane Central 和 Web of Science。我们的主要结果是血糖≤250 mg/dl 的时间和酸中毒缓解的时间。次要结果包括每小时血糖下降率、低血糖发生率、低钾血症、治疗失败和脑水肿。结果和结论:本研究证实,低剂量胰岛素治疗糖尿病酮症酸中毒儿科患者的疗效与标准剂量相当,且并发症发生率较低。
{"title":"Low dose insulin infusion versus the standard dose in children with diabetic ketoacidosis: a meta-analysis.","authors":"Mohamed Mohamed Belal, Basma Badrawy Khalefa, Eslam Mohammed Rabea, Mazen Negmeldin Aly Yassin, Mohamed Nabih Bashir, Malak Mohamed Abd El-Hameed, Omar Elkoumi, Saad Mohamed Saad, Loubna Mohamed Saad, Mohamed Hamouda Elkasaby","doi":"10.2144/fsoa-2023-0137","DOIUrl":"10.2144/fsoa-2023-0137","url":null,"abstract":"<p><p><b>Aim:</b> This systematic review aims to consolidate findings from current clinical trials that compare the effectiveness of insulin infusion at 0.05 IU/kg/h versus 0.1 IU/kg/h in managing pediatric diabetic ketoacidosis. <b>Methods:</b> We searched several databases, including PubMed, Embase, Scopus, Cochrane Central and Web of Science. Our primary outcomes were time to reach blood glucose ≤250 mg/dl and time to resolution of acidosis. Secondary outcomes included rate of blood glucose decrease per hour, incidence of hypoglycemia, hypokalemia, treatment failure, and cerebral edema. <b>Results & conclusion:</b> The present study establishes that a low insulin dose exhibits comparable efficacy to the standard dosage for managing pediatric patients suffering from diabetic ketoacidosis, with a lower incidence of complications.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO956"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financial hardship after cancer: revision of a conceptual model and development of patient-reported outcome measures. 癌症后的经济困难:概念模型的修订和患者报告结果测量方法的开发。
IF 2.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-05-14 eCollection Date: 2024-01-01 DOI: 10.2144/fsoa-2023-0229
Salene Mw Jones, Jean Yi, Nora B Henrikson, Laura Panattoni, Veena Shankaran

Aim: This qualitative study refined a conceptual model of financial hardship and developed measures corresponding to model constructs. Methods: Eighteen women with breast cancer recruited through a comprehensive cancer center completed interviews. A qualitative framework analysis was conducted of the interviews. Results: Participants experienced varying levels of financial hardship. Protective factors included good health insurance, work accommodations and social support. Participants worried about cancer care costs and employment. Programs for alleviating financial hardship had high administrative burdens. Four preliminary financial hardship measures were developed: coping, impacts, depression and worry. Conclusion: Reducing administrative barriers to benefits could reduce financial hardship after cancer. More research is needed on the effects of out-of-network/formulary care and denials of coverage and to validate the measures.

目的:本定性研究完善了经济困难的概念模型,并制定了与模型结构相对应的测量方法。研究方法通过综合癌症中心招募的 18 名乳腺癌妇女完成了访谈。对访谈内容进行了定性框架分析。结果参与者经历了不同程度的经济困难。保护因素包括良好的医疗保险、工作便利和社会支持。参与者担心癌症治疗费用和就业问题。减轻经济困难的计划具有较高的行政负担。初步制定了四种经济困难测量方法:应对、影响、抑郁和担忧。结论减少福利方面的行政障碍可以减轻癌症后的经济困难。还需要对网络外/处方照护和拒绝承保的影响进行更多研究,并对衡量标准进行验证。
{"title":"Financial hardship after cancer: revision of a conceptual model and development of patient-reported outcome measures.","authors":"Salene Mw Jones, Jean Yi, Nora B Henrikson, Laura Panattoni, Veena Shankaran","doi":"10.2144/fsoa-2023-0229","DOIUrl":"10.2144/fsoa-2023-0229","url":null,"abstract":"<p><p><b>Aim:</b> This qualitative study refined a conceptual model of financial hardship and developed measures corresponding to model constructs. <b>Methods:</b> Eighteen women with breast cancer recruited through a comprehensive cancer center completed interviews. A qualitative framework analysis was conducted of the interviews. <b>Results:</b> Participants experienced varying levels of financial hardship. Protective factors included good health insurance, work accommodations and social support. Participants worried about cancer care costs and employment. Programs for alleviating financial hardship had high administrative burdens. Four preliminary financial hardship measures were developed: coping, impacts, depression and worry. <b>Conclusion:</b> Reducing administrative barriers to benefits could reduce financial hardship after cancer. More research is needed on the effects of out-of-network/formulary care and denials of coverage and to validate the measures.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"10 1","pages":"FSO983"},"PeriodicalIF":2.5,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future Science OA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1